Andy Merritt

1.3k total citations
32 papers, 816 citations indexed

About

Andy Merritt is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Andy Merritt has authored 32 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Computational Theory and Mathematics and 6 papers in Organic Chemistry. Recurrent topics in Andy Merritt's work include Computational Drug Discovery Methods (10 papers), Microbial Natural Products and Biosynthesis (4 papers) and Asymmetric Synthesis and Catalysis (3 papers). Andy Merritt is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Microbial Natural Products and Biosynthesis (4 papers) and Asymmetric Synthesis and Catalysis (3 papers). Andy Merritt collaborates with scholars based in United Kingdom, United States and Germany. Andy Merritt's co-authors include Duncan B. Judd, John Brown, Peter N. Lowe, Guizhu Hong, Liang Ye, Andrew Lockhart, Antony D. Gee, Kristian Birchall, Catherine Kettleborough and Elizabeth R. Quinn and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Organic Chemistry and Frontiers in Immunology.

In The Last Decade

Andy Merritt

30 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy Merritt United Kingdom 15 430 224 172 161 95 32 816
Marina Tintelnot‐Blomley Switzerland 17 463 1.1× 217 1.0× 249 1.4× 222 1.4× 53 0.6× 29 879
W. Mei Kok Australia 14 448 1.0× 142 0.6× 69 0.4× 224 1.4× 61 0.6× 20 729
Per-Olof Markgren Sweden 13 631 1.5× 164 0.7× 133 0.8× 178 1.1× 100 1.1× 13 1.1k
Alexander Flohr Switzerland 11 397 0.9× 204 0.9× 206 1.2× 149 0.9× 47 0.5× 18 740
L. Michel Espinoza‐Fonseca United States 20 833 1.9× 125 0.6× 119 0.7× 64 0.4× 98 1.0× 59 1.1k
D.S. Williamson United Kingdom 16 693 1.6× 272 1.2× 118 0.7× 62 0.4× 44 0.5× 26 1.2k
Heiko Kroth United States 20 931 2.2× 313 1.4× 89 0.5× 303 1.9× 94 1.0× 55 1.5k
Markus Boehringer Switzerland 10 588 1.4× 209 0.9× 158 0.9× 52 0.3× 116 1.2× 11 898
Corinne Kay United Kingdom 11 452 1.1× 303 1.4× 191 1.1× 55 0.3× 65 0.7× 14 796

Countries citing papers authored by Andy Merritt

Since Specialization
Citations

This map shows the geographic impact of Andy Merritt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Merritt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Merritt more than expected).

Fields of papers citing papers by Andy Merritt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Merritt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Merritt. The network helps show where Andy Merritt may publish in the future.

Co-authorship network of co-authors of Andy Merritt

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Merritt. A scholar is included among the top collaborators of Andy Merritt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Merritt. Andy Merritt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouloc, Nathalie, Ning Wang, Péter A. Szijj, et al.. (2025). Formation of mono- and dual-labelled antibody fragment conjugates via reversible site-selective disulfide modification and proximity induced lysine reactivity. Chemical Science. 16(6). 2763–2776. 1 indexed citations
2.
Muwaffak, Zaid, et al.. (2025). Optimising digital twin laboratories with conversational AIs: enhancing immersive training and simulation through virtual reality. Digital Discovery. 4(5). 1134–1141. 3 indexed citations
3.
Kalms, Jacqueline, Helena Wright, Frederick W. Muskett, et al.. (2023). Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discovery. Frontiers in Immunology. 14. 1216967–1216967. 1 indexed citations
4.
Ortega‐Gómez, Almudena, Sanne L. Maas, José Garrido‐Mesa, et al.. (2021). Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists. European Journal of Medicinal Chemistry. 226. 113805–113805. 4 indexed citations
5.
Ortega‐Gómez, Almudena, Sanne L. Maas, Mauro Perretti, et al.. (2021). Synthesis and evaluation of novel cyclopentane urea FPR2 agonists and their potential application in the treatment of cardiovascular inflammation. European Journal of Medicinal Chemistry. 214. 113194–113194. 9 indexed citations
6.
Canning, Peter, Kristian Birchall, Catherine Kettleborough, Andy Merritt, & P.J. Coombs. (2020). Fragment-based target screening as an empirical approach to prioritising targets: a case study on antibacterials. Drug Discovery Today. 25(11). 2030–2037. 7 indexed citations
7.
Large, Jonathan M., Kristian Birchall, Nathalie Bouloc, et al.. (2019). Potent bicyclic inhibitors of malarial cGMP-dependent protein kinase: approaches to combining improvements in cell potency, selectivity and structural novelty. Bioorganic & Medicinal Chemistry Letters. 29(19). 126610–126610. 11 indexed citations
8.
Large, Jonathan M., et al.. (2018). Developing an Antibody–Drug Conjugate Approach to Selective Inhibition of an Extracellular Protein. ChemBioChem. 20(6). 754–758. 15 indexed citations
9.
Birchall, Kristian, Nathalie Bouloc, Jonathan M. Large, et al.. (2018). Trisubstituted thiazoles as potent and selective inhibitors of Plasmodium falciparum protein kinase G (PfPKG). Bioorganic & Medicinal Chemistry Letters. 28(19). 3168–3173. 20 indexed citations
10.
Birchall, Kristian, et al.. (2018). Design of the LifeArc Index Set and Retrospective Review of Its Performance: A Collection for Sharing. SLAS DISCOVERY. 24(3). 332–345. 5 indexed citations
11.
Large, Jonathan M., Kristian Birchall, Nathalie Bouloc, et al.. (2018). Potent inhibitors of malarial P. Falciparum protein kinase G: Improving the cell activity of a series of imidazopyridines. Bioorganic & Medicinal Chemistry Letters. 29(3). 509–514. 14 indexed citations
12.
Zhyvoloup, Alexander, Anat Melamed, Delphine Planas, et al.. (2017). Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation. PLoS Pathogens. 13(7). e1006460–e1006460. 21 indexed citations
13.
Southern, C., Jennifer M. Cook, Debra L. Taylor, et al.. (2013). Screening β-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein–Coupled Receptors. SLAS DISCOVERY. 18(5). 599–609. 150 indexed citations
14.
Morley, Andrew, Angelo Pugliese, Kristian Birchall, et al.. (2013). Fragment-based hit identification: thinking in 3D. Drug Discovery Today. 18(23-24). 1221–1227. 129 indexed citations
15.
Saxty, Barbara, Andy Merritt, Marta Nekulová, et al.. (2013). A Casein kinase 1/Checkpoint kinase 1 pyrazolo-pyridine protein kinase inhibitor as novel activator of the p53 pathway. Bioorganic & Medicinal Chemistry Letters. 23(20). 5578–5585. 12 indexed citations
16.
Lockhart, Andrew, Liang Ye, Duncan B. Judd, et al.. (2004). Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on β-Amyloid Peptide Fibrils. Journal of Biological Chemistry. 280(9). 7677–7684. 184 indexed citations
17.
Merritt, Andy. (2003). Combinatorial Approaches to Asymmetric Catalysis.. ChemInform. 34(5). 1 indexed citations
18.
Green, Rachel, et al.. (2003). A practical synthesis of enantiopure (S)-4-(4-hydroxybenzyl)-oxazolidin-2-one. Tetrahedron Asymmetry. 14(17). 2619–2623. 17 indexed citations
19.
Merritt, Andy. (2002). Combinatorial Library Design and Evaluation: Principles, Software Tools and Applications in Drug Discovery. Drug Discovery Today. 7(1). 28–28. 18 indexed citations
20.
Cox, Brian J., Andy Merritt, Jane Denyer, et al.. (2000). Application of High-throughput Screening Techniques to Drug Discovery. Progress in medicinal chemistry. 37. 83–133. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Tintelnot‐Blomley Breakdown of academic impact, for papers by W. Mei Kok Breakdown of academic impact, for papers by Per-Olof Markgren Breakdown of academic impact, for papers by Alexander Flohr Breakdown of academic impact, for papers by L. Michel Espinoza‐Fonseca Breakdown of academic impact, for papers by D.S. Williamson Breakdown of academic impact, for papers by Heiko Kroth Breakdown of academic impact, for papers by Markus Boehringer Breakdown of academic impact, for papers by Corinne Kay
Rankless by CCL
2026